Marine n‐3 Polyunsaturated Fatty Acids Mitigate Obesity Traits Through PRDM16‐Driven Gene–Nutrient Interaction and Spatiotemporal Scale Browning Process

ABSTRACT Marine n‐3 polyunsaturated fatty acids (PUFAs) as functional lipids are pivotal in controlling obesity but the mechanism is poorly understood. Herein, we unravel the role of n‐3 PUFAs in mitigating obesity traits through gene–nutrient interactions and white‐to‐brown adipose conversion. Data from 45,664 UK Biobank participants followed for 8.7 years were analyzed using Cox proportional hazards regression. The metabolites of eicosapentaenoic acid (EPA)/docosahexaenoic acid (DHA)‐treated adipocytes during different spatiotemporal stages were measured by high‐resolution mass spectroscopy. Habitual fish oil consumption was associated with 12% and 7% lower risk of obesity and high body fat percentage, respectively. Notably, fish oil had significant interactions with the variants of PRDM16 at rs60330317, rs2493212, rs2483239, and rs2297828. DHA and EPA supplementation reduced body weight and serum total cholesterol level in diet‐induced obese mice. Metabolomics profiling of subcutaneous adipose tissue revealed that both DHA and EPA significantly decreased the concentrations of glutamic acid and glutamine while enhancing glutathione. The spatiotemporal metabolomics further revealed that DHA/EPA mainly manipulates the metabolites involved in white‐to‐brown adipose conversion. Consistently, DHA and EPA treatments induce browning process, reduce the formation of lipid droplets, and promote mitochondrial function during the differentiation of adipocytes. Mechanistically, n‐3 PUFAs suppressed PPARγ acetylation and PRDM16 ubiquitination while knocking down the expression of PRDM16 that blocked the browning effect. In addition, they downregulate the expression of miRNA‐378a and miRNA‐34a. These findings indicate that DHA and EPA prevent adiposity by promoting adipocyte browning in the PRDM16‐dependent way and support the use of fish oil supplements as a preemptive therapy for obesity control.

Authors

Institutions

Publication Details

Journal
Food Frontiers
Published
2025-11-20
DOI
https://doi.org/10.1002/fft2.70174
Primary Topic
Fatty Acid Research and Health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Marine n‐3 Polyunsaturated Fatty Acids Mitigate Obesity Traits Through PRDM16‐Driven Gene–Nutrient Interaction and Spatiotemporal Scale Browning Process

Xuzhi Wan, Jianxin Yao, Haoyin Liu, Haoyu Li et al.
Food Frontiers
Fatty Acid Research and Health
article

Marine n‐3 Polyunsaturated Fatty Acids Mitigate Obesity Traits Through PRDM16‐Driven Gene–Nutrient Interaction and Spatiotemporal Scale Browning Process

Xuzhi Wan, Jianxin Yao, Haoyin Liu, Haoyu Li, Jingjing Jiao, Hongbo Shi, Xiaohui Liu, Yu Zhang, Jia Wei, Xiaoqian Chen, Youyou Zheng, Pan Zhuang, Xunan Lin
article en

Abstract

ABSTRACT Marine n‐3 polyunsaturated fatty acids (PUFAs) as functional lipids are pivotal in controlling obesity but the mechanism is poorly understood. Herein, we unravel the role of n‐3 PUFAs in mitigating obesity traits through gene–nutrient interactions and white‐to‐brown adipose conversion. Data from 45,664 UK Biobank participants followed for 8.7 years were analyzed using Cox proportional hazards regression. The metabolites of eicosapentaenoic acid (EPA)/docosahexaenoic acid (DHA)‐treated adipocytes during different spatiotemporal stages were measured by high‐resolution mass spectroscopy. Habitual fish oil consumption was associated with 12% and 7% lower risk of obesity and high body fat percentage, respectively. Notably, fish oil had significant interactions with the variants of PRDM16 at rs60330317, rs2493212, rs2483239, and rs2297828. DHA and EPA supplementation reduced body weight and serum total cholesterol level in diet‐induced obese mice. Metabolomics profiling of subcutaneous adipose tissue revealed that both DHA and EPA significantly decreased the concentrations of glutamic acid and glutamine while enhancing glutathione. The spatiotemporal metabolomics further revealed that DHA/EPA mainly manipulates the metabolites involved in white‐to‐brown adipose conversion. Consistently, DHA and EPA treatments induce browning process, reduce the formation of lipid droplets, and promote mitochondrial function during the differentiation of adipocytes. Mechanistically, n‐3 PUFAs suppressed PPARγ acetylation and PRDM16 ubiquitination while knocking down the expression of PRDM16 that blocked the browning effect. In addition, they downregulate the expression of miRNA‐378a and miRNA‐34a. These findings indicate that DHA and EPA prevent adiposity by promoting adipocyte browning in the PRDM16‐dependent way and support the use of fish oil supplements as a preemptive therapy for obesity control.

Food FrontiersVol. 7(2)
Second Affiliated Hospital of Zhejiang University (CN), Zhejiang University (CN)
National Institute for Health and Care Research, King's College London, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province
Openalex Percentile: Top 58%
Fatty Acid Research and Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.